GlassScriptPhysician profile
Rohini D Thodge
NPI 1003026147
$3,152.59
in general payments reported to CMS, 2019-2025
38 companies · $396 in 2025
The $396 reported for 2025 was more than what 90% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $472 · 2021: $501 · 2022: $414 · 2023: $537 · 2024: $507 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,439.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $503.97 | 2020-2024 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $404.76 | 2019-2024 | Repatha, Otezla |
| Merck Sharp & Dohme LLC | $385.86 | 2019-2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Glaxosmithkline, LLC. | $185.35 | 2019-2025 | Penmenvy, Trelegy Ellipta, Shingrix |
| Pfizer INC. | $176.73 | 2019-2025 | |
| Myriad Women'S Health, INC. | $126.03 | 2023 | Myrisk |
| Lilly USA, LLC | $122.92 | 2019-2025 | Mounjaro |
| Abbott Laboratories | $101.68 | 2019-2023 | Freestyle Libre 3 |
| Daiichi Sankyo INC. | $88.78 | 2020-2022 | |
| Gilead Sciences, INC. | $85.75 | 2023-2025 | |
| Exact Sciences Corporation | $79.10 | 2023-2025 | Cologuard Collection Kit |
| Supernus Pharmaceuticals, INC. | $73.25 | 2022-2025 | Qelbree |
| Janssen Pharmaceuticals, INC | $70.22 | 2020-2021 | |
| Grifols USA, LLC | $64.82 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $64.72 | 2021 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohini Thodge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.